Canine Mobility & Comfort | Monthly Veterinary Injection
Librela may control osteoarthritis pain for some dogs. The decision starts with an examination, a realistic benefit-risk discussion, and a plan to monitor the activities that matter in your dog’s daily life.
The short answer
Librela is one possible layer in an individualized arthritis plan
Librela (bedinvetmab injection) is a prescription veterinary medicine administered under the skin once a month to control pain associated with osteoarthritis in dogs. It targets nerve growth factor, a protein involved in transmitting pain signals.
Librela controls pain; it does not treat, slow, or reverse the progression of arthritis. Your veterinarian should consider the whole dog and review treatment before every injection.
Start with the changes you see at home
Mobility changes can have more than one cause. An examination helps determine what is happening before a treatment plan is chosen.
Getting up and settling
Stiffness after rest, repeated attempts to rise, difficulty getting comfortable, or needing more assistance.
Walking and stairs
Slower pace, tiring earlier, limping, favoring a leg, hesitating on steps, or avoiding familiar routes.
Everyday participation
Less interest in play, difficulty entering the car, reluctance to jump, or withdrawing from normal family activities.
What Librela does—and what monthly care involves
Targets an osteoarthritis pain pathway
Bedinvetmab is a canine monoclonal antibody that binds to nerve growth factor. It is designed for the control of pain associated with osteoarthritis in dogs.
Requires clinic administration and follow-up
The veterinary team gives the injection once a month. There is no daily Librela pill, but response, mobility, activity, and possible adverse effects still need to be reviewed over time.
Video description
A dog runs through a grassy field and along a path. On-screen text prompts viewers to recognize signs of osteoarthritis pain and describes Librela as a once-monthly osteoarthritis treatment for dogs, followed by Librela and Cascade Veterinary Clinics branding and a make-an-appointment prompt. The surrounding page provides the medication’s benefits, limitations, candidacy, monitoring, and safety context.
What improvement may look like
For a dog who responds, the meaningful outcome is a repeatable change in real life—not a promise that arthritis is gone.
Comfort during familiar movement
You may notice easier rising, a steadier usual walk, less hesitation on stairs, or more willingness to participate in normal routines.
A response that still needs monitoring
Response and timing vary. A dog may improve, show little change, or stop responding later. New mobility or health changes should be discussed rather than automatically attributed to arthritis.
Is Librela appropriate for my dog?
Candidacy is an individualized veterinary decision. Bring an accurate list of medications and supplements and describe any recently changed health or mobility problems.
The evaluation may include
- A physical examination and mobility or pain assessment
- Medical history and current medications or supplements
- Previous or current monoclonal-antibody treatment
- Diagnostic testing or imaging when indicated
- A plan for monitoring comfort, activity, and adverse effects
Tell the team about new concerns
Report new or recently changed balance, walking, standing, seizure, urinary, appetite, gastrointestinal, or other health concerns. Further testing may be recommended before starting or continuing treatment.
If pain has limited activity, ask for a gradual return-to-activity plan rather than a sudden increase.
Important candidacy limits
Librela should not be used in breeding, pregnant, or lactating dogs. Its safety and effectiveness have not been evaluated in dogs younger than 12 months. Your veterinarian should also review hypersensitivity history and concurrent treatment considerations.
Benefits and safety should be discussed before every injection
Contact your veterinarian if you notice balance problems, trouble walking or standing, weakness, paralysis, seizures, increased drinking or urination, loss of bladder control, vomiting, diarrhea, loss of appetite, marked lethargy, or another concerning change.
Serious adverse reactions can occur, with or without warning, and in some situations may result in death. Post-approval reports do not always establish that Librela caused an event, but they are important when considering and monitoring treatment.
Read the current FDA-approved Librela labeling and Client Information Sheet
This page provides general education and does not replace an examination, diagnosis, or individualized veterinary advice.
What happens next
A useful plan connects the treatment decision to concrete follow-up rather than treating a monthly injection as an isolated event.
Evaluate
Identify what may be causing the mobility change and whether osteoarthritis is involved.
Decide together
Review realistic benefits, material limitations, candidacy, monitoring, cost, and other pain-management options.
Measure and recheck
Track a few repeatable activities and report both improvement and possible adverse effects before continued treatment.
Frequently Asked Questions
How often does my dog get Librela?
Librela is administered as an injection under the skin once a month by the veterinary team. Before every injection, your veterinarian should review how your dog is doing, discuss the current Client Information Sheet and possible adverse events, and decide with you whether treatment should continue.
How quickly will I notice a difference?
Response varies, and it may take two monthly injections to notice a reduction in pain. If your dog does not respond as hoped after the second injection—or stops responding after later injections—talk with your veterinarian about whether another pain-management approach would be more appropriate.
Is Librela a pill I give at home?
No. Librela is an injection administered in the clinic by the veterinary team, so there is no daily Librela pill to give at home.
Can Librela help older dogs with arthritis?
Librela may be an option for some older dogs with osteoarthritis pain, but age alone does not determine candidacy. A veterinary examination is needed to review mobility, current or recently changed health problems, medications and supplements, previous or current monoclonal-antibody treatment, and individual benefit-risk considerations. Librela should not be given to dogs younger than 12 months or to dogs intended for breeding, pregnant, or nursing.
Does my dog still need an exam before starting Librela?
Yes. Librela requires a veterinary prescription and administration. An examination helps identify what is causing discomfort, determine whether osteoarthritis is involved, review your dog’s health history and medications, and decide whether Librela or another pain-management plan is appropriate. Further testing may be recommended if your dog has new or recently changed health problems.
Choose the right next step
Talk with Cascade about your dog’s mobility
Established clients can call Wenatchee to request the appropriate arthritis-pain appointment. New clients can submit the intake form and ask to be contacted about scheduling.
For non-scheduling questions, use Cascade’s contact page. The intake form states that scheduling-contact requests are typically answered within 72 hours.